Ukraine pharma seeks clarification on undue pressure and interference by law enforcement authorities

17 October 2016

Ukraine’s pharmaceutical trade association APRaD, in cooperation with organizations representing international pharmaceutical manufacturers and business in general such as US-Ukraine Business Council, Association of International Pharmaceutical Manufacturers AIMP Ukraine and Indian Pharmaceutical Manufacturer’s Association (IPMA), has signed a letter concerning actions of law enforcement in the Ukraine pharmaceutical market.

The letter is addressed it to the government of Ukraine with a copy to the Head of the EU Delegation to Ukraine and the US Ambassador to Ukraine.

In the inquiry the organizations emphasize the undue pressure and interference in the affairs of the pharmaceutical market participants by the law enforcement authorities and ask to take actions to prevent undue pressure on, and unreasonable interference in the affairs of the pharmaceutical market participants, cause it may affect adversely the timely and continuous patients’ access to medicines.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK